 6. a. Concomitant treatment with anti-TNF-alpha therapy or other biological therapy and systemic immunosuppressive agents such as cyclosporine, mycophenolate, pimecrolimus, or tacrolimus, except azathioprine, its metabolite 6-MP and MTX. 